Patent · US Active

Ligand

US9321832B2 · kind B2 · utility

9Cited by

38References

7Claims

0Family size

Assignee

Domantis Limited · GB

Inventors

Ian Tomlinson · Stevenage, GB
Laurent Jespers · Tervuren, BE
Jasper Clube · Cambridge, GB
Lucy J. Holt · Cambridge, GB
Oliver Schon · Cambridge, GB

Key dates

Filing date	Feb 8, 2007
Grant date	Apr 26, 2016
Priority date	—
Expiry date	Dec 25, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a dual-specific ligand comprising a first immunoglobulin variable domain having a first binding specificity and a complementary or non-complementary immunoglobulin variable domain having a second binding specificity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.